Healthcare Sector Stocks
The Healthcare sector has a total of 1057 stocks, with a combined market cap of $8.43 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.90.
Market Cap
8.43T
Revenue
4.59T
Profits
201.33B
PE Ratio
41.90
Profit Margin
4.39%
Dividend Yield
0.43%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.00T | 4.31% | 4,046,373 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 549.25B | 2.21% | 7,270,349 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 397.42B | 3.60% | 6,799,092 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 360.05B | 5.16% | 12,666,047 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 297.02B | 4.85% | 15,933,947 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 282.41B | 3.13% | 2,030,343 | 60.44B |
| 7 | NVS | Novartis AG | 268.86B | 3.30% | 2,488,992 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 195.68B | 4.17% | 16,533,411 | 50.57B |
| 9 | AMGN | Amgen Inc. | 186.52B | 2.18% | 2,907,080 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 179.13B | 1.70% | 2,256,753 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.39B | 0.15% | 13,729,148 | 29.74B |
| 12 | ABT | Abbott Laboratories | 158.12B | 4.36% | 14,152,818 | 45.13B |
| 13 | ISRG | Intuitive Surgical, Inc. | 148.33B | 2.83% | 2,353,302 | 10.58B |
| 14 | PFE | Pfizer Inc. | 146.42B | 1.38% | 31,268,135 | 63.32B |
| 15 | DHR | Danaher Corporation | 132.10B | 4.81% | 7,771,207 | 24.78B |
| 16 | CVS | CVS Health Corporation | 120.98B | 3.78% | 12,339,711 | 405.62B |
| 17 | BMY | Bristol-Myers Squibb Company | 115.58B | 3.44% | 12,657,892 | 48.48B |
| 18 | SYK | Stryker Corporation | 115.47B | 2.11% | 2,476,788 | 25.27B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 112.12B | 3.13% | 1,362,202 | 12.22B |
| 20 | SNY | Sanofi | 106.66B | 4.74% | 2,230,261 | 54.60B |
| 21 | MDT | Medtronic plc | 105.19B | 5.11% | 19,849,517 | 36.36B |
| 22 | GSK | GSK plc | 102.00B | 3.12% | 3,894,029 | 43.29B |
| 23 | MCK | McKesson Corporation | 90.99B | 2.36% | 902,675 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 88.91B | 4.64% | 1,424,860 | 200.42B |
| 25 | HCA | HCA Healthcare, Inc. | 80.27B | -0.39% | 1,891,474 | 76.39B |
| 26 | CI | The Cigna Group | 74.25B | 4.28% | 2,551,090 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 72.61B | 2.43% | 22,773,718 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.97B | 1.58% | 974,643 | 14.92B |
| 29 | ARGX | argenx SE | 52.69B | 3.58% | 228,927 | 4.74B |
| 30 | COR | Cencora, Inc. | 52.59B | 2.53% | 1,498,052 | 328.68B |
| 31 | EW | Edwards Lifesciences Corporation | 50.35B | 1.69% | 4,530,644 | 6.30B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 47.89B | 2.79% | 2,653,465 | 28.34B |
| 33 | CAH | Cardinal Health, Inc. | 47.25B | 3.01% | 2,338,259 | 250.74B |
| 34 | MDLN | Medline Inc. | 45.26B | -0.06% | 13,273,953 | 29.14B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.55B | 0.72% | 631,289 | 4.45B |
| 36 | HUM | Humana Inc. | 42.00B | 6.80% | 1,892,284 | 137.20B |
| 37 | BDX | Becton, Dickinson and Company | 41.21B | 2.71% | 2,241,656 | 22.23B |
| 38 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.54B | 3.78% | 1,081,375 | 4.29B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 40.09B | 4.87% | 5,575,658 | 17.35B |
| 40 | HLN | Haleon plc | 39.25B | 2.75% | 9,519,571 | 14.85B |
| 41 | A | Agilent Technologies, Inc. | 39.08B | 0.71% | 2,126,423 | 7.23B |
| 42 | WAT | Waters Corporation | 36.96B | -0.87% | 952,812 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 33.34B | 2.49% | 7,355,153 | 9.53B |
| 44 | RVMD | Revolution Medicines, Inc. | 33.10B | -0.19% | 2,608,582 | - |
| 45 | ALC | Alcon Inc. | 32.20B | 3.67% | 2,317,103 | 10.63B |
| 46 | NTRA | Natera, Inc. | 31.81B | 4.84% | 1,265,991 | 2.50B |
| 47 | RPRX | Royalty Pharma plc | 31.68B | 0.09% | 4,588,439 | 2.44B |
| 48 | IQV | IQVIA Holdings Inc. | 31.19B | 2.65% | 1,676,397 | 16.63B |
| 49 | ONC | BeOne Medicines AG | 31.12B | 0.33% | 99,471 | 5.70B |
| 50 | CNC | Centene Corporation | 30.96B | 5.29% | 5,835,617 | 178.33B |
| 51 | VEEV | Veeva Systems Inc. | 29.15B | -0.07% | 3,619,419 | 3.32B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.03B | 2.87% | 4,468,797 | 20.98B |
| 53 | BIIB | Biogen Inc. | 29.00B | 0.25% | 719,051 | 9.94B |
| 54 | RMD | ResMed Inc. | 28.06B | 4.22% | 1,573,567 | 5.54B |
| 55 | DXCM | DexCom, Inc. | 28.01B | -0.25% | 6,370,341 | 4.82B |
| 56 | ILMN | Illumina, Inc. | 25.43B | -1.68% | 2,605,973 | 4.39B |
| 57 | PHG | Koninklijke Philips N.V. | 24.77B | 2.52% | 961,162 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 23.85B | 0.95% | 183,611 | 4.09B |
| 59 | UTHR | United Therapeutics Corporation | 23.25B | -0.32% | 411,932 | 3.17B |
| 60 | INSM | Insmed Incorporated | 22.74B | 1.02% | 1,849,170 | 819.56M |
| 61 | BNTX | BioNTech SE | 22.66B | 1.29% | 860,971 | 3.23B |
| 62 | WST | West Pharmaceutical Services, Inc. | 22.42B | 0.32% | 629,127 | 3.22B |
| 63 | DGX | Quest Diagnostics Incorporated | 21.71B | 1.27% | 735,926 | 11.28B |
| 64 | LH | Labcorp Holdings Inc. | 21.40B | 0.79% | 519,649 | 14.14B |
| 65 | ROIV | Roivant Sciences Ltd. | 21.24B | 2.89% | 4,244,384 | 8.26M |
| 66 | STE | STERIS plc | 20.72B | 0.98% | 998,554 | 5.94B |
| 67 | MRNA | Moderna, Inc. | 20.47B | 5.16% | 6,709,676 | 2.23B |
| 68 | INCY | Incyte Corporation | 20.23B | 3.33% | 1,780,001 | 5.36B |
| 69 | VTRS | Viatris Inc. | 18.52B | 2.19% | 7,504,071 | 14.56B |
| 70 | GH | Guardant Health, Inc. | 17.64B | 4.75% | 2,014,198 | 1.08B |
| 71 | NBIX | Neurocrine Biosciences, Inc. | 16.83B | 1.36% | 1,301,575 | 3.10B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.77B | 2.01% | 1,623,412 | 8.41B |
| 73 | GMAB | Genmab A/S | 15.12B | 3.56% | 1,240,289 | 3.90B |
| 74 | JAZZ | Jazz Pharmaceuticals plc | 15.06B | 3.95% | 1,296,605 | 4.44B |
| 75 | SOLV | Solventum Corporation | 14.27B | 5.18% | 2,488,592 | 8.26B |
| 76 | THC | Tenet Healthcare Corporation | 13.90B | -2.11% | 1,812,707 | 21.46B |
| 77 | ASND | Ascendis Pharma A/S | 13.59B | 0.95% | 485,720 | 998.25M |
| 78 | EXEL | Exelixis, Inc. | 13.19B | 1.72% | 2,409,501 | 2.38B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 13.19B | 2.83% | 1,968,800 | 579.96M |
| 80 | MEDP | Medpace Holdings, Inc. | 13.10B | 1.75% | 221,318 | 2.68B |
| 81 | SNN | Smith & Nephew plc | 12.99B | 3.07% | 2,434,494 | 6.16B |
| 82 | PEN | Penumbra, Inc. | 12.61B | 0.39% | 823,433 | 1.45B |
| 83 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | 1.77% | 1,241,122 | 1.06B |
| 84 | ELAN | Elanco Animal Health Incorporated | 12.34B | 0.57% | 7,598,642 | 4.89B |
| 85 | DVA | DaVita Inc. | 12.34B | -1.47% | 676,859 | 13.84B |
| 86 | COO | The Cooper Companies, Inc. | 12.10B | 2.78% | 4,059,683 | 4.23B |
| 87 | ALGN | Align Technology, Inc. | 12.05B | 4.07% | 979,558 | 4.10B |
| 88 | AXSM | Axsome Therapeutics, Inc. | 11.91B | -0.86% | 557,778 | 708.24M |
| 89 | BTSG | BrightSpring Health Services, Inc. | 11.80B | -5.72% | 10,792,094 | 13.65B |
| 90 | FMS | Fresenius Medical Care AG | 11.78B | 4.93% | 744,907 | 22.32B |
| 91 | ICLR | ICON Public Limited Company | 11.70B | 6.18% | 1,689,848 | 8.25B |
| 92 | SMMT | Summit Therapeutics Inc. | 11.52B | -1.53% | 5,414,589 | - |
| 93 | RVTY | Revvity, Inc. | 11.42B | 1.32% | 863,890 | 2.90B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.36B | 0.96% | 219,096 | 1.13B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.02B | 1.69% | 1,309,291 | 3.58B |
| 96 | RGC | Regencell Bioscience Holdings Limited | 10.98B | -6.69% | 113,343 | - |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.91B | 3.31% | 2,077,384 | 3.24B |
| 98 | GMED | Globus Medical, Inc. | 10.86B | 2.63% | 1,328,128 | 3.10B |
| 99 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.59B | 3.60% | 1,130,252 | 622.01M |
| 100 | PODD | Insulet Corporation | 10.14B | 2.17% | 1,410,367 | 2.90B |
| 101 | MOH | Molina Healthcare, Inc. | 10.04B | 4.32% | 1,004,568 | 43.10B |
| 102 | BAX | Baxter International Inc. | 9.99B | 4.37% | 5,752,226 | 11.32B |
| 103 | EHC | Encompass Health Corporation | 9.90B | -3.23% | 1,135,983 | 6.07B |
| 104 | CYTK | Cytokinetics, Incorporated | 9.81B | 2.23% | 1,312,415 | 105.82M |
| 105 | ENSG | The Ensign Group, Inc. | 9.52B | -1.43% | 643,271 | 5.27B |
| 106 | TEM | Tempus AI, Inc. | 9.38B | 10.00% | 13,897,343 | 1.36B |
| 107 | MASI | Masimo Corporation | 9.37B | 0.07% | 951,946 | 1.56B |
| 108 | BRKR | Bruker Corporation | 9.13B | -4.35% | 5,790,146 | 3.46B |
| 109 | KRYS | Krystal Biotech, Inc. | 9.07B | 1.98% | 264,886 | 417.30M |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.95B | 3.29% | 736,748 | 4.03B |
| 111 | HSIC | Henry Schein, Inc. | 8.69B | 0.74% | 1,359,753 | 13.38B |
| 112 | UHS | Universal Health Services, Inc. | 8.64B | -2.23% | 1,081,008 | 17.76B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.49B | 2.55% | 2,232,343 | 1.51B |
| 114 | TECH | Bio-Techne Corporation | 8.33B | 4.58% | 4,200,692 | 1.21B |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 8.23B | 0.87% | 279,055 | 2.59B |
| 116 | CORT | Corcept Therapeutics Incorporated | 8.04B | 3.08% | 909,792 | 769.10M |
| 117 | ABVX | ABIVAX Société Anonyme | 7.78B | 16.39% | 5,261,316 | 5.67M |
| 118 | QGEN | Qiagen N.V. | 7.77B | 3.05% | 2,863,320 | 2.10B |
| 119 | IBRX | ImmunityBio, Inc. | 7.64B | 1.53% | 9,612,074 | 140.98M |
| 120 | NUVL | Nuvalent, Inc. | 7.43B | 4.26% | 937,856 | - |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 7.38B | -5.08% | 1,084,488 | 7.46M |
| 122 | ALKS | Alkermes plc | 7.23B | 1.45% | 2,307,052 | 1.56B |
| 123 | HQY | HealthEquity, Inc. | 7.19B | 0.96% | 784,245 | 1.34B |
| 124 | ATR | AptarGroup, Inc. | 7.18B | 0.02% | 337,581 | 3.87B |
| 125 | GKOS | Glaukos Corporation | 7.14B | 7.08% | 1,584,247 | 551.35M |
| 126 | RGEN | Repligen Corporation | 7.14B | 3.96% | 1,190,177 | 763.34M |
| 127 | OSCR | Oscar Health, Inc. | 7.11B | 15.12% | 10,721,394 | 13.30B |
| 128 | PCVX | Vaxcyte, Inc. | 7.04B | 3.90% | 1,232,786 | - |
| 129 | SYRE | Spyre Therapeutics, Inc. | 6.82B | 6.75% | 1,119,152 | - |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.81B | 7.97% | 1,471,227 | - |
| 131 | IMVT | Immunovant, Inc. | 6.71B | 4.88% | 1,343,004 | - |
| 132 | LNTH | Lantheus Holdings, Inc. | 6.69B | 2.56% | 826,233 | 1.55B |
| 133 | PTGX | Protagonist Therapeutics, Inc. | 6.61B | 7.74% | 658,834 | 74.06M |
| 134 | AVTR | Avantor, Inc. | 6.50B | 4.96% | 11,111,297 | 6.55B |
| 135 | HIMS | Hims & Hers Health, Inc. | 6.48B | 1.82% | 24,042,482 | 2.37B |
| 136 | GRFS | Grifols, S.A. | 6.43B | 1.47% | 390,545 | 8.58B |
| 137 | LEGN | Legend Biotech Corporation | 6.35B | -4.95% | 3,415,167 | 1.14B |
| 138 | CNTA | Centessa Pharmaceuticals plc | 6.16B | -0.13% | 1,972,660 | 15.00M |
| 139 | KYMR | Kymera Therapeutics, Inc. | 6.14B | 1.91% | 752,699 | 51.48M |
| 140 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | 3.42% | 392,964 | 217.17M |
| 141 | PACS | PACS Group, Inc. | 5.93B | 2.66% | 752,672 | 5.43B |
| 142 | PTCT | PTC Therapeutics, Inc. | 5.86B | 2.85% | 1,098,008 | 827.11M |
| 143 | TFX | Teleflex Incorporated | 5.85B | 2.76% | 481,242 | 2.13B |
| 144 | TGTX | TG Therapeutics, Inc. | 5.75B | 1.12% | 2,343,068 | 700.35M |
| 145 | CHE | Chemed Corporation | 5.72B | 1.28% | 216,977 | 2.54B |
| 146 | BLTE | Belite Bio, Inc | 5.68B | 5.27% | 312,655 | - |
| 147 | MIRM | Mirum Pharmaceuticals, Inc. | 5.64B | 0.71% | 697,667 | 569.61M |
| 148 | COGT | Cogent Biosciences, Inc. | 5.60B | 1.64% | 1,600,253 | - |
| 149 | LQDA | Liquidia Corporation | 5.56B | 12.30% | 4,398,357 | 288.07M |
| 150 | CRSP | CRISPR Therapeutics AG | 5.49B | 9.35% | 3,300,963 | 4.10M |
| 151 | BLCO | Bausch + Lomb Corporation | 5.47B | 3.23% | 388,414 | 5.21B |
| 152 | SRRK | Scholar Rock Holding Corporation | 5.43B | 1.55% | 856,201 | - |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.12B | -0.88% | 1,365,367 | 7.50M |
| 154 | STVN | Stevanato Group S.p.A. | 5.05B | -0.11% | 182,618 | 1.39B |
| 155 | CGON | CG Oncology, Inc. | 4.95B | 3.07% | 653,905 | 5.07M |
| 156 | CAI | Caris Life Sciences, Inc. | 4.88B | 11.63% | 3,197,929 | 907.29M |
| 157 | HNGE | Hinge Health, Inc. | 4.87B | 7.36% | 2,101,251 | 646.34M |
| 158 | BLLN | BillionToOne, Inc. | 4.81B | 6.33% | 1,162,598 | 354.54M |
| 159 | LGND | Ligand Pharmaceuticals Incorporated | 4.73B | 0.68% | 230,386 | 274.48M |
| 160 | TWST | Twist Bioscience Corporation | 4.60B | 2.21% | 2,041,820 | 409.48M |
| 161 | DNTH | Dianthus Therapeutics, Inc. | 4.60B | -1.00% | 901,584 | 1.34M |
| 162 | CELC | Celcuity Inc. | 4.51B | 3.96% | 3,961,114 | - |
| 163 | SHC | Sotera Health Company | 4.44B | 1.96% | 2,778,116 | 1.19B |
| 164 | AMRX | Amneal Pharmaceuticals, Inc. | 4.31B | 4.97% | 1,743,116 | 3.05B |
| 165 | TVTX | Travere Therapeutics, Inc. | 4.29B | 2.17% | 1,609,913 | 536.20M |
| 166 | TXG | 10x Genomics, Inc. | 4.25B | 4.17% | 4,152,196 | 638.78M |
| 167 | MANE | Veradermics, Incorporated | 4.23B | 4.64% | 439,779 | - |
| 168 | RDNT | RadNet, Inc. | 4.15B | 1.81% | 1,124,560 | 2.14B |
| 169 | ERAS | Erasca, Inc. | 4.13B | 0.68% | 7,958,314 | - |
| 170 | LIVN | LivaNova PLC | 4.05B | 3.35% | 573,415 | 1.43B |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.01B | 2.82% | 909,404 | - |
| 172 | VCYT | Veracyte, Inc. | 3.98B | 2.57% | 1,644,863 | 541.74M |
| 173 | MMED | MiniMed Group, Inc. | 3.95B | -1.40% | 1,263,010 | 3.10B |
| 174 | WAY | Waystar Holding Corp. | 3.88B | 3.53% | 1,674,739 | 1.16B |
| 175 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.83B | 0.03% | 1,025,333 | 596.96M |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.82B | 1.74% | 1,457,526 | 22.57M |
| 177 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.79B | 2.88% | 470,477 | 754.05M |
| 178 | DOCS | Doximity, Inc. | 3.79B | -1.62% | 3,743,599 | 644.86M |
| 179 | MMSI | Merit Medical Systems, Inc. | 3.76B | 3.94% | 635,855 | 1.54B |
| 180 | ORKA | Oruka Therapeutics, Inc. | 3.76B | 8.88% | 1,477,697 | - |
| 181 | NVST | Envista Holdings Corporation | 3.72B | 2.10% | 2,776,908 | 2.81B |
| 182 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 1.35% | 1,122,668 | 1.10B |
| 183 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.65B | 4.65% | 1,090,541 | 18.07M |
| 184 | IRTC | iRhythm Holdings, Inc. | 3.53B | 2.82% | 830,928 | 787.85M |
| 185 | OGN | Organon & Co. | 3.52B | - | 1,326,125 | 6.16B |
| 186 | VKTX | Viking Therapeutics, Inc. | 3.46B | 1.53% | 1,726,020 | - |
| 187 | ICUI | ICU Medical, Inc. | 3.37B | 3.34% | 266,821 | 2.16B |
| 188 | BEAM | Beam Therapeutics Inc. | 3.27B | 11.13% | 4,393,647 | 164.01M |
| 189 | TNGX | Tango Therapeutics, Inc. | 3.20B | 3.17% | 1,247,586 | 56.99M |
| 190 | DNLI | Denali Therapeutics Inc. | 3.20B | 2.44% | 1,833,121 | - |
| 191 | CON | Concentra Group Holdings Parent, Inc. | 3.19B | 0.69% | 747,398 | 2.23B |
| 192 | HAE | Haemonetics Corporation | 3.17B | 6.03% | 1,215,541 | 1.33B |
| 193 | RLAY | Relay Therapeutics, Inc. | 3.17B | -4.97% | 5,790,401 | 10.68M |
| 194 | OPCH | Option Care Health, Inc. | 3.15B | -2.24% | 2,510,896 | 5.67B |
| 195 | ITGR | Integer Holdings Corporation | 3.15B | 2.04% | 309,781 | 1.86B |
| 196 | TLX | Telix Pharmaceuticals Limited | 3.12B | 8.78% | 463,501 | 803.79M |
| 197 | ALHC | Alignment Healthcare, Inc. | 3.12B | 5.75% | 6,521,868 | 4.26B |
| 198 | RCUS | Arcus Biosciences, Inc. | 3.11B | 3.48% | 632,543 | 236.00M |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.04B | 2.33% | 1,446,144 | - |
| 200 | LFST | LifeStance Health Group, Inc. | 2.96B | 1.87% | 1,652,072 | 1.49B |
| 201 | WRBY | Warby Parker Inc. | 2.96B | -0.41% | 1,481,251 | 890.57M |
| 202 | NHC | National HealthCare Corporation | 2.94B | 0.85% | 77,585 | 1.53B |
| 203 | ADPT | Adaptive Biotechnologies Corporation | 2.89B | 13.07% | 4,416,006 | 295.41M |
| 204 | GRAL | GRAIL, Inc. | 2.86B | 8.87% | 1,276,435 | 156.12M |
| 205 | BKD | Brookdale Senior Living Inc. | 2.84B | -2.94% | 6,329,835 | 3.00B |
| 206 | GPCR | Structure Therapeutics Inc. | 2.78B | 4.16% | 643,061 | - |
| 207 | ARQT | Arcutis Biotherapeutics, Inc. | 2.75B | 2.81% | 1,173,406 | 415.62M |
| 208 | KLRA | Kailera Therapeutics, Inc. | 2.72B | -6.21% | 489,281 | - |
| 209 | IRON | Disc Medicine, Inc. | 2.72B | 1.08% | 469,176 | - |
| 210 | PRVA | Privia Health Group, Inc. | 2.69B | 3.44% | 956,405 | 2.25B |
| 211 | DFTX | Definium Therapeutics, Inc. | 2.68B | 4.24% | 2,564,327 | - |
| 212 | ALMS | Alumis Inc. | 2.60B | 1.54% | 729,523 | 8.40M |
| 213 | TARS | Tarsus Pharmaceuticals, Inc. | 2.60B | 2.69% | 433,032 | 535.08M |
| 214 | SUPN | Supernus Pharmaceuticals, Inc. | 2.59B | 1.50% | 460,501 | 776.83M |
| 215 | GRDN | Guardian Pharmacy Services, Inc. | 2.58B | 4.24% | 494,852 | 1.46B |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.57B | 2.89% | 687,710 | 225.27M |
| 217 | HTFL | HeartFlow, Inc. | 2.48B | -0.14% | 1,469,509 | 191.42M |
| 218 | TMDX | TransMedics Group, Inc. | 2.47B | 2.41% | 908,493 | 635.89M |
| 219 | GMRS | GMR Solutions Inc. | 2.45B | 1.11% | 617,148 | 5.74B |
| 220 | VERA | Vera Therapeutics, Inc. | 2.40B | 6.75% | 2,982,010 | - |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.35B | 0.54% | 592,043 | 865.00K |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.32B | -2.02% | 3,924,826 | 3.37B |
| 223 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | 4.02% | 1,412,117 | 670.00M |
| 224 | AXGN | Axogen, Inc. | 2.25B | 4.33% | 1,043,673 | 238.11M |
| 225 | ESTA | Establishment Labs Holdings Inc. | 2.25B | 5.63% | 813,967 | 229.58M |
| 226 | IMNM | Immunome, Inc. | 2.23B | -0.66% | 878,435 | 4.02M |
| 227 | PHVS | Pharvaris N.V. | 2.20B | 4.94% | 361,807 | - |
| 228 | ELVN | Enliven Therapeutics, Inc. | 2.16B | -1.50% | 1,098,929 | - |
| 229 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.15B | 2.67% | 3,465,371 | 885.72M |
| 230 | PBH | Prestige Consumer Healthcare Inc. | 2.15B | - | 552,457 | 1.09B |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.14B | 2.10% | 309,972 | 256.28M |
| 232 | KOD | Kodiak Sciences Inc. | 2.13B | 0.86% | 749,581 | - |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 4.47% | 2,628,757 | 298.30M |
| 234 | CLOV | Clover Health Investments, Corp. | 2.10B | 9.32% | 7,458,579 | 2.21B |
| 235 | NVCR | NovoCure Limited | 2.08B | 11.39% | 2,251,161 | 674.41M |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.07B | -0.04% | 2,699,470 | - |
| 237 | NTLA | Intellia Therapeutics, Inc. | 2.06B | 13.29% | 9,609,094 | 66.09M |
| 238 | SEM | Select Medical Holdings Corporation | 2.05B | - | 824,696 | 5.52B |
| 239 | RXRX | Recursion Pharmaceuticals, Inc. | 2.02B | 9.51% | 38,926,307 | 66.41M |
| 240 | NKTR | Nektar Therapeutics | 2.00B | 0.14% | 1,136,358 | 55.63M |
| 241 | PGNY | Progyny, Inc. | 2.00B | 1.96% | 953,836 | 1.29B |
| 242 | HCM | HUTCHMED (China) Limited | 1.99B | -1.24% | 97,731 | 548.51M |
| 243 | NEOG | Neogen Corporation | 1.99B | 3.52% | 1,887,677 | 870.56M |
| 244 | OMCL | Omnicell, Inc. | 1.98B | 4.08% | 419,580 | 1.23B |
| 245 | XRAY | DENTSPLY SIRONA Inc. | 1.98B | 2.49% | 6,594,203 | 3.68B |
| 246 | TRVI | Trevi Therapeutics, Inc. | 1.98B | 3.57% | 877,514 | - |
| 247 | BHC | Bausch Health Companies Inc. | 1.96B | 6.26% | 3,176,701 | 10.53B |
| 248 | IOVA | Iovance Biotherapeutics, Inc. | 1.96B | 15.57% | 22,606,829 | 285.61M |
| 249 | ZLAB | Zai Lab Limited | 1.95B | 0.99% | 666,205 | 453.28M |
| 250 | ABCL | AbCellera Biologics Inc. | 1.94B | 11.36% | 11,445,943 | 79.21M |
| 251 | OCUL | Ocular Therapeutix, Inc. | 1.93B | 5.39% | 1,824,482 | 52.04M |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 1.91B | 2.68% | 639,409 | 899.11M |
| 253 | GENB | Generate Biomedicines, Inc. | 1.88B | 13.87% | 2,512,956 | 30.30M |
| 254 | ASTH | Astrana Health, Inc. | 1.88B | 3.11% | 547,785 | 3.53B |
| 255 | STOK | Stoke Therapeutics, Inc. | 1.88B | 2.24% | 595,730 | 32.08M |
| 256 | MESO | Mesoblast Limited | 1.87B | 2.82% | 144,256 | 65.38M |
| 257 | PLSE | Pulse Biosciences, Inc. | 1.87B | 7.94% | 640,655 | 751.00K |
| 258 | ADMA | ADMA Biologics, Inc. | 1.85B | 2.84% | 2,203,228 | 509.86M |
| 259 | LKFT | Lakefront Biotherapeutics NV | 1.84B | 2.18% | 148,928 | 1.20B |
| 260 | NBTX | Nanobiotix S.A. | 1.84B | 4.86% | 19,839 | 38.27M |
| 261 | ZYME | Zymeworks Inc. | 1.83B | 3.08% | 467,167 | 81.26M |
| 262 | VRDN | Viridian Therapeutics, Inc. | 1.83B | 1.35% | 1,194,836 | 70.92M |
| 263 | VCEL | Vericel Corporation | 1.82B | 2.73% | 707,277 | 292.09M |
| 264 | NUVB | Nuvation Bio Inc. | 1.80B | 9.53% | 6,720,367 | 143.05M |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.79B | 2.43% | 694,571 | 1.93B |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.79B | 1.32% | 203,974 | 20.00M |
| 267 | SGRY | Surgery Partners, Inc. | 1.77B | 1.26% | 1,543,115 | 3.34B |
| 268 | QURE | uniQure N.V. | 1.77B | -6.33% | 3,182,302 | 18.09M |
| 269 | CMPS | COMPASS Pathways plc | 1.76B | 2.84% | 3,532,723 | - |
| 270 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | 2.59% | 2,339,342 | 2.18B |
| 271 | UFPT | UFP Technologies, Inc. | 1.74B | 2.82% | 129,602 | 608.85M |
| 272 | BHVN | Biohaven Ltd. | 1.72B | 5.46% | 3,427,019 | - |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 1.71B | 4.01% | 648,157 | 66.05M |
| 274 | SION | Sionna Therapeutics, Inc. | 1.71B | 2.94% | 362,897 | - |
| 275 | TSHA | Taysha Gene Therapies, Inc. | 1.69B | 6.13% | 2,600,928 | 7.47M |
| 276 | AAPG | Ascentage Pharma Group International | 1.69B | 2.29% | 4,850 | 82.08M |
| 277 | SLS | SELLAS Life Sciences Group, Inc. | 1.68B | 10.38% | 8,435,789 | - |
| 278 | ANIP | ANI Pharmaceuticals, Inc. | 1.68B | 5.28% | 548,944 | 923.71M |
| 279 | NVAX | Novavax, Inc. | 1.68B | -0.10% | 5,248,628 | 596.34M |
| 280 | WGS | GeneDx Holdings Corp. | 1.67B | 6.13% | 1,631,029 | 442.68M |
| 281 | ATAI | AtaiBeckley Inc. | 1.65B | -0.66% | 4,553,833 | 3.49M |
| 282 | PVLA | Palvella Therapeutics, Inc. | 1.65B | -0.52% | 207,650 | - |
| 283 | ADUS | Addus HomeCare Corporation | 1.64B | 1.28% | 223,316 | 1.45B |
| 284 | INVA | Innoviva, Inc. | 1.64B | 2.12% | 720,244 | 420.69M |
| 285 | FTRE | Fortrea Holdings Inc. | 1.63B | 10.36% | 2,990,663 | 2.71B |
| 286 | CAPR | Capricor Therapeutics, Inc. | 1.62B | 1.12% | 584,153 | 11.13M |
| 287 | TYRA | Tyra Biosciences, Inc. | 1.62B | -5.26% | 1,294,209 | - |
| 288 | SNDX | Syndax Pharmaceuticals, Inc. | 1.60B | -1.74% | 7,796,253 | 217.17M |
| 289 | GHRS | GH Research PLC | 1.60B | -4.83% | 282,683 | - |
| 290 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.59B | 8.41% | 2,240,288 | -665.00K |
| 291 | AGL | agilon health, inc. | 1.59B | 15.15% | 305,034 | 5.82B |
| 292 | NRIX | Nurix Therapeutics, Inc. | 1.58B | -1.29% | 1,578,348 | 71.78M |
| 293 | SNDA | Sonida Senior Living, Inc. | 1.55B | -1.34% | 759,047 | 367.34M |
| 294 | VIR | Vir Biotechnology, Inc. | 1.54B | 4.33% | 1,444,551 | 65.50M |
| 295 | AVBP | ArriVent BioPharma, Inc. | 1.54B | 11.11% | 744,729 | - |
| 296 | PRCT | PROCEPT BioRobotics Corporation | 1.54B | 2.54% | 874,437 | 322.02M |
| 297 | ANAB | AnaptysBio, Inc. | 1.50B | 0.84% | 323,965 | 232.39M |
| 298 | ALMR | Alamar Biosciences, Inc. | 1.49B | 2.63% | 133,318 | 87.16M |
| 299 | STAA | STAAR Surgical Company | 1.49B | 5.66% | 489,127 | 290.38M |
| 300 | PRGO | Perrigo Company plc | 1.48B | 2.01% | 2,569,166 | 4.18B |
| 301 | NEO | NeoGenomics, Inc. | 1.47B | 11.54% | 2,498,764 | 745.97M |
| 302 | MBX | MBX Biosciences, Inc. | 1.47B | 2.86% | 544,022 | - |
| 303 | GLUE | Monte Rosa Therapeutics, Inc. | 1.47B | -1.31% | 729,623 | 42.95M |
| 304 | IMCR | Immunocore Holdings plc | 1.46B | 0.38% | 300,741 | 412.81M |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | -2.21% | 1,709,270 | 2.52B |
| 306 | KALV | KalVista Pharmaceuticals, Inc. | 1.43B | - | 826,064 | 114.48M |
| 307 | SEPN | Septerna, Inc. | 1.41B | 2.68% | 290,672 | 72.26M |
| 308 | MAZE | Maze Therapeutics, Inc. | 1.41B | 2.17% | 455,859 | 20.00M |
| 309 | HCSG | Healthcare Services Group, Inc. | 1.40B | 1.29% | 716,856 | 1.85B |
| 310 | ATRC | AtriCure, Inc. | 1.38B | 4.01% | 839,406 | 552.16M |
| 311 | MLTX | MoonLake Immunotherapeutics | 1.38B | 2.46% | 439,729 | - |
| 312 | PGEN | Precigen, Inc. | 1.38B | 1.31% | 4,089,889 | 31.60M |
| 313 | DMRA | Damora Therapeutics, Inc. | 1.37B | -0.09% | 458,616 | - |
| 314 | IART | Integra LifeSciences Holdings Corporation | 1.37B | 9.07% | 984,760 | 1.64B |
| 315 | IMTX | Immatics N.V. | 1.37B | -0.15% | 456,058 | 43.00M |
| 316 | MPLT | MapLight Therapeutics, Inc. | 1.36B | 6.21% | 397,280 | - |
| 317 | BFLY | Butterfly Network, Inc. | 1.36B | 18.22% | 8,825,339 | 102.92M |
| 318 | URGN | UroGen Pharma Ltd. | 1.34B | 3.76% | 329,752 | 140.49M |
| 319 | SVRA | Savara Inc. | 1.34B | 0.95% | 1,026,853 | - |
| 320 | BCAX | Bicara Therapeutics Inc. | 1.34B | 2.05% | 298,177 | - |
| 321 | PAHC | Phibro Animal Health Corporation | 1.34B | 3.93% | 704,540 | 1.50B |
| 322 | INBX | Inhibrx Biosciences, Inc. | 1.34B | -4.17% | 388,715 | 1.30M |
| 323 | ARDX | Ardelyx, Inc. | 1.33B | -0.37% | 2,572,475 | 427.68M |
| 324 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 7.88% | 2,414,905 | 1.03B |
| 325 | BLFS | BioLife Solutions, Inc. | 1.32B | -0.59% | 520,083 | 101.66M |
| 326 | TDOC | Teladoc Health, Inc. | 1.32B | 3.10% | 3,444,428 | 2.51B |
| 327 | ENOV | Enovis Corporation | 1.32B | 6.03% | 766,469 | 2.28B |
| 328 | AHCO | AdaptHealth Corp. | 1.30B | 0.10% | 1,245,700 | 3.29B |
| 329 | HROW | Harrow, Inc. | 1.29B | 4.11% | 546,662 | 268.68M |
| 330 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | 3.10% | 4,447,250 | 204.73M |
| 331 | PSNL | Personalis, Inc. | 1.27B | 12.24% | 5,547,004 | 64.52M |
| 332 | AHG | Akso Health Group | 1.25B | 0.69% | 4,469 | 14.84M |
| 333 | ARDT | Ardent Health, Inc. | 1.23B | 9.83% | 1,533,754 | 6.43B |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.22B | 3.13% | 2,060,164 | 787.08M |
| 335 | INSP | Inspire Medical Systems, Inc. | 1.22B | 4.33% | 839,916 | 915.25M |
| 336 | IRMD | IRADIMED CORPORATION | 1.20B | 2.69% | 319,259 | 86.28M |
| 337 | CDNA | CareDx, Inc. | 1.19B | 3.63% | 1,603,939 | 412.82M |
| 338 | KMTS | Kestra Medical Technologies, Ltd. | 1.19B | 8.66% | 569,349 | 83.72M |
| 339 | AMN | AMN Healthcare Services, Inc. | 1.19B | 0.99% | 858,438 | 3.42B |
| 340 | NNNN | Anbio Biotechnology | 1.19B | -5.26% | 28,412 | 8.65M |
| 341 | SDGR | Schrödinger, Inc. | 1.18B | 6.16% | 2,498,143 | 254.91M |
| 342 | WVE | Wave Life Sciences Ltd. | 1.17B | 5.73% | 3,420,986 | 71.80M |
| 343 | ALVO | Alvotech | 1.17B | 19.11% | 1,483,037 | 562.04M |
| 344 | AVNS | Avanos Medical, Inc. | 1.17B | 0.08% | 1,409,257 | 715.90M |
| 345 | ZBIO | Zenas BioPharma, Inc. | 1.16B | 5.63% | 508,432 | 10.00M |
| 346 | ABSI | Absci Corporation | 1.14B | 23.57% | 9,193,635 | 1.84M |
| 347 | AVLN | Avalyn Pharma Inc. | 1.13B | 2.23% | 215,960 | - |
| 348 | COAG | Hemab Therapeutics Holdings, Inc. | 1.12B | -3.13% | 105,729 | - |
| 349 | OPK | OPKO Health, Inc. | 1.10B | - | 2,625,351 | 581.12M |
| 350 | AKTS | Aktis Oncology, Inc. | 1.10B | 2.68% | 151,653 | 8.28M |
| 351 | MNKD | MannKind Corporation | 1.09B | 4.76% | 3,519,408 | 360.78M |
| 352 | OMDA | Omada Health, Inc. | 1.08B | 5.08% | 969,137 | 283.30M |
| 353 | XERS | Xeris Biopharma Holdings, Inc. | 1.06B | 4.41% | 2,307,586 | 314.85M |
| 354 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 5.25% | 350,122 | 796.33M |
| 355 | CNMD | CONMED Corporation | 1.06B | 6.26% | 588,334 | 1.37B |
| 356 | EVO | Evotec SE | 1.06B | 2.77% | 37,187 | 859.03M |
| 357 | AZTA | Azenta, Inc. | 1.05B | -4.40% | 1,345,923 | 596.48M |
| 358 | CRON | Cronos Group Inc. | 1.05B | 3.32% | 1,020,240 | 159.54M |
| 359 | PNTG | The Pennant Group, Inc. | 1.05B | -0.76% | 323,500 | 1.02B |
| 360 | QDEL | QuidelOrtho Corporation | 1.04B | 12.50% | 2,149,001 | 2.66B |
| 361 | DBVT | DBV Technologies S.A. | 1.03B | -0.68% | 173,347 | 5.74M |
| 362 | EYPT | EyePoint, Inc. | 1.03B | -0.65% | 815,092 | 7.61M |
| 363 | AORT | Artivion, Inc. | 1.01B | 1.26% | 1,010,444 | 458.69M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 985.54M | 1.03% | 807,127 | - |
| 365 | INNV | InnovAge Holding Corp. | 977.30M | 1.69% | 401,893 | 949.17M |
| 366 | GDRX | GoodRx Holdings, Inc. | 965.22M | 1.42% | 1,339,518 | 787.89M |
| 367 | SPTX | Seaport Therapeutics, Inc. | 948.14M | 3.77% | 122,210 | - |
| 368 | USPH | U.S. Physical Therapy, Inc. | 940.06M | -0.16% | 191,997 | 787.69M |
| 369 | OLMA | Olema Pharmaceuticals, Inc. | 932.87M | 1.62% | 1,064,288 | - |
| 370 | NUTX | Nutex Health Inc. | 929.67M | 1.71% | 122,514 | 879.95M |
| 371 | DRTS | Alpha Tau Medical Ltd. | 927.91M | -2.74% | 1,476,976 | - |
| 372 | SPRY | ARS Pharmaceuticals, Inc. | 900.68M | 3.66% | 817,486 | 98.99M |
| 373 | ANNX | Annexon, Inc. | 892.94M | 1.11% | 3,229,357 | - |
| 374 | PCRX | Pacira BioSciences, Inc. | 892.02M | 1.57% | 518,264 | 734.86M |
| 375 | XNCR | Xencor, Inc. | 890.44M | 5.17% | 942,670 | 97.36M |
| 376 | PHAR | Pharming Group N.V. | 890.00M | 0.41% | 11,663 | 369.49M |
| 377 | CGEM | Cullinan Therapeutics, Inc. | 886.84M | -5.13% | 984,147 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 886.27M | 1.92% | 572,423 | 79.76M |
| 379 | IVA | Inventiva S.A. | 881.34M | 4.70% | 1,919,228 | 7.94M |
| 380 | JBIO | Jade Biosciences, Inc. | 875.64M | 0.85% | 3,508,939 | - |
| 381 | CERT | Certara, Inc. | 872.72M | 0.18% | 3,763,263 | 419.75M |
| 382 | TALK | Talkspace, Inc. | 871.07M | -0.19% | 1,706,967 | 238.37M |
| 383 | INMD | InMode Ltd. | 862.95M | 0.96% | 406,165 | 374.64M |
| 384 | ABUS | Arbutus Biopharma Corporation | 859.29M | - | 732,411 | 191.45M |
| 385 | LXRX | Lexicon Pharmaceuticals, Inc. | 843.97M | 2.70% | 1,756,835 | 69.64M |
| 386 | TBPH | Theravance Biopharma, Inc. | 843.92M | 2.83% | 409,756 | 109.78M |
| 387 | JANX | Janux Therapeutics, Inc. | 839.45M | 1.29% | 620,981 | 13.73M |
| 388 | AVR | Anteris Technologies Global Corp. | 833.37M | 7.82% | 2,130,738 | 1.85M |
| 389 | ORIC | ORIC Pharmaceuticals, Inc. | 830.21M | 2.30% | 1,068,335 | - |
| 390 | LBRX | LB Pharmaceuticals Inc | 829.90M | 3.54% | 167,861 | - |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 824.54M | 3.20% | 459,231 | 720.53M |
| 392 | SANA | Sana Biotechnology, Inc. | 823.74M | -5.13% | 4,219,938 | - |
| 393 | REPL | Replimune Group, Inc. | 814.99M | -1.10% | 7,095,001 | - |
| 394 | ESPR | Esperion Therapeutics, Inc. | 805.76M | -0.32% | 8,810,475 | 418.24M |
| 395 | ODTX | Odyssey Therapeutics, Inc. | 801.96M | 1.86% | 200,529 | 2.98M |
| 396 | LMRI | Lumexa Imaging Holdings, Inc. | 791.71M | 5.92% | 572,675 | 1.03B |
| 397 | ETON | Eton Pharmaceuticals, Inc. | 791.64M | 4.67% | 721,997 | 86.93M |
| 398 | PHAT | Phathom Pharmaceuticals, Inc. | 783.18M | -2.28% | 1,038,044 | 204.89M |
| 399 | KURA | Kura Oncology, Inc. | 778.55M | 1.27% | 2,094,020 | 71.64M |
| 400 | GERN | Geron Corporation | 776.24M | 4.31% | 9,830,723 | 196.12M |
| 401 | VOR | Vor Biopharma Inc. | 775.94M | 6.55% | 661,619 | - |
| 402 | SSII | SS Innovations International, Inc. | 767.77M | -10.90% | 133,820 | 48.47M |
| 403 | BIOA | BioAge Labs, Inc. | 756.59M | 6.11% | 271,953 | 10.32M |
| 404 | AURA | Aura Biosciences, Inc. | 750.04M | -1.16% | 492,043 | - |
| 405 | DRUG | Bright Minds Biosciences Inc. | 749.19M | 0.11% | 824,960 | - |
| 406 | EVMN | Evommune, Inc. | 745.22M | 4.87% | 440,294 | 10.00M |
| 407 | OMER | Omeros Corporation | 741.85M | 0.89% | 1,407,036 | 9.89M |
| 408 | HSTM | HealthStream, Inc. | 738.85M | 3.06% | 230,465 | 311.78M |
| 409 | BVS | Bioventus Inc. | 726.75M | 1.75% | 836,175 | 576.30M |
| 410 | AVTX | Avalo Therapeutics, Inc. | 715.42M | -0.95% | 1,353,601 | 59.00K |
| 411 | OCS | Oculis Holding AG | 714.39M | -9.97% | 1,345,748 | 1.40M |
| 412 | SLDB | Solid Biosciences Inc. | 712.78M | 5.69% | 1,009,088 | - |
| 413 | CBLL | CeriBell, Inc. | 711.43M | 9.14% | 347,368 | 95.07M |
| 414 | ALLO | Allogene Therapeutics, Inc. | 704.12M | 2.00% | 7,340,764 | 22.00K |
| 415 | ANRO | Alto Neuroscience, Inc. | 702.11M | 6.26% | 366,838 | - |
| 416 | CTMX | CytomX Therapeutics, Inc. | 692.30M | -1.24% | 3,240,406 | 35.54M |
| 417 | CADL | Candel Therapeutics, Inc. | 679.22M | 5.34% | 2,853,488 | - |
| 418 | DSGN | Design Therapeutics, Inc. | 672.04M | 3.07% | 388,359 | - |
| 419 | CRMD | CorMedix Inc. | 669.98M | 3.77% | 1,446,830 | 400.05M |
| 420 | RLMD | Relmada Therapeutics, Inc. | 661.86M | -0.32% | 817,109 | - |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 660.32M | 1.92% | 949,633 | 122.29M |
| 422 | SIBN | SI-BONE, Inc. | 659.92M | 6.90% | 471,789 | 206.22M |
| 423 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 659.28M | 2.49% | 93,748 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 657.82M | 6.56% | 1,065,953 | 8.37M |
| 425 | CSTL | Castle Biosciences, Inc. | 655.13M | 5.93% | 293,251 | 339.92M |
| 426 | TENX | Tenax Therapeutics, Inc. | 652.96M | 2.97% | 883,552 | - |
| 427 | SGP | SpyGlass Pharma, Inc. | 650.82M | 3.66% | 58,500 | - |
| 428 | TRAX | First Tracks Biotherapeutics, Inc. | 635.04M | 18.80% | 536,153 | - |
| 429 | PRME | Prime Medicine, Inc. | 626.74M | 10.51% | 3,844,567 | 4.03M |
| 430 | TLRY | Tilray Brands, Inc. | 619.08M | 1.57% | 2,985,313 | 858.28M |
| 431 | BBNX | Beta Bionics, Inc. | 618.96M | 11.57% | 1,323,904 | 110.24M |
| 432 | CBIO | Crescent Biopharma, Inc. | 613.08M | 2.61% | 157,832 | 11.88M |
| 433 | PHR | Phreesia, Inc. | 598.96M | 0.41% | 1,473,467 | 495.59M |
| 434 | DNA | Ginkgo Bioworks Holdings, Inc. | 591.19M | 3.67% | 4,187,246 | 151.40M |
| 435 | IMMX | Immix Biopharma, Inc. | 587.64M | -0.24% | 1,224,034 | - |
| 436 | AGMB | AgomAb Therapeutics NV | 585.56M | -0.92% | 125,434 | - |
| 437 | CABA | Cabaletta Bio, Inc. | 572.32M | -1.96% | 3,825,916 | - |
| 438 | BWAY | BrainsWay Ltd. | 570.88M | 1.64% | 59,309 | 56.22M |
| 439 | ALT | Altimmune, Inc. | 567.86M | 1.74% | 2,818,662 | 36.00K |
| 440 | TCMD | Tactile Systems Technology, Inc. | 567.74M | 3.28% | 224,215 | 343.52M |
| 441 | GYRE | Gyre Therapeutics, Inc. | 565.59M | 8.79% | 133,671 | 117.05M |
| 442 | MDXG | MiMedx Group, Inc. | 563.01M | 4.71% | 1,328,783 | 389.42M |
| 443 | RIGL | Rigel Pharmaceuticals, Inc. | 559.69M | -0.17% | 230,310 | 299.77M |
| 444 | IRWD | Ironwood Pharmaceuticals, Inc. | 559.69M | 4.94% | 1,876,681 | 361.51M |
| 445 | CTKB | Cytek Biosciences, Inc. | 559.19M | 6.91% | 706,051 | 204.17M |
| 446 | CERS | Cerus Corporation | 559.03M | 4.89% | 3,134,572 | 216.56M |
| 447 | PROK | ProKidney Corp. | 558.81M | 6.94% | 740,302 | 889.00K |
| 448 | NPCE | NeuroPace, Inc. | 556.41M | 2.77% | 184,475 | 99.53M |
| 449 | FLGT | Fulgent Genetics, Inc. | 553.81M | 7.50% | 603,164 | 320.35M |
| 450 | TECX | Tectonic Therapeutic, Inc. | 549.66M | 2.50% | 65,217 | - |
| 451 | ACHV | Achieve Life Sciences, Inc. | 543.07M | 7.52% | 1,290,536 | - |
| 452 | SRTA | Strata Critical Medical, Inc. | 541.66M | 0.81% | 776,466 | 228.58M |
| 453 | VALN | Valneva SE | 538.38M | 1.61% | 20,628 | 180.25M |
| 454 | INDP | Indaptus Therapeutics, Inc. | 537.90M | 114.93% | 44,275,489 | - |
| 455 | XOMA | XOMA Royalty Corporation | 531.74M | 1.68% | 133,431 | 48.56M |
| 456 | EIKN | Eikon Therapeutics, Inc. | 529.48M | 3.71% | 283,207 | - |
| 457 | FDMT | 4D Molecular Therapeutics, Inc. | 523.29M | 5.04% | 1,051,796 | 88.24M |
| 458 | CLYM | Climb Bio, Inc. | 521.15M | 4.50% | 1,119,097 | - |
| 459 | AQST | Aquestive Therapeutics, Inc. | 519.36M | 2.73% | 1,937,724 | 50.27M |
| 460 | PACB | Pacific Biosciences of California, Inc. | 506.28M | 3.16% | 7,876,095 | 160.03M |
| 461 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 462 | ANGO | AngioDynamics, Inc. | 501.44M | 7.41% | 231,111 | 313.73M |
| 463 | ARVN | Arvinas, Inc. | 499.39M | 0.52% | 575,010 | 89.40M |
| 464 | LAB | Standard BioTools Inc. | 495.77M | 11.40% | 3,867,443 | 86.26M |
| 465 | EVH | Evolent Health, Inc. | 492.67M | 15.87% | 3,086,317 | 1.89B |
| 466 | PRTA | Prothena Corporation plc | 484.27M | 3.70% | 504,872 | 57.94M |
| 467 | KYTX | Kyverna Therapeutics, Inc. | 481.22M | 1.66% | 631,613 | - |
| 468 | ASMB | Assembly Biosciences, Inc. | 477.79M | -1.87% | 215,193 | 71.10M |
| 469 | STRO | Sutro Biopharma, Inc. | 475.24M | 5.52% | 250,103 | 99.61M |
| 470 | TOI | The Oncology Institute, Inc. | 473.92M | 12.06% | 2,597,211 | 545.76M |
| 471 | RZLT | Rezolute, Inc. | 471.15M | -1.53% | 2,210,478 | - |
| 472 | CTEV | Claritev Corporation | 470.01M | 4.95% | 99,903 | 978.76M |
| 473 | KIDS | OrthoPediatrics Corp. | 464.90M | 6.91% | 155,093 | 243.30M |
| 474 | OCGN | Ocugen, Inc. | 463.77M | 5.38% | 3,531,864 | 4.47M |
| 475 | OVID | Ovid Therapeutics Inc. | 462.87M | 3.77% | 1,276,297 | 7.12M |
| 476 | CTNM | Contineum Therapeutics, Inc. | 459.85M | -1.44% | 245,758 | - |
| 477 | CCCC | C4 Therapeutics, Inc. | 459.45M | 5.30% | 1,548,645 | 34.86M |
| 478 | WEAV | Weave Communications, Inc. | 459.09M | 1.58% | 629,296 | 248.72M |
| 479 | EDIT | Editas Medicine, Inc. | 458.85M | 7.55% | 2,512,167 | 38.69M |
| 480 | MOBI | Mobia Medical, Inc. | 457.90M | 0.80% | 240,618 | 32.04M |
| 481 | NRC | NRC Health | 443.63M | 3.39% | 134,786 | 138.64M |
| 482 | MYGN | Myriad Genetics, Inc. | 442.96M | 6.59% | 1,638,733 | 829.00M |
| 483 | AUTL | Autolus Therapeutics plc | 441.80M | 2.47% | 1,272,723 | 92.62M |
| 484 | VREX | Varex Imaging Corporation | 440.64M | 3.00% | 412,130 | 857.50M |
| 485 | ANL | Adlai Nortye Ltd. | 440.00M | -2.31% | 98,035 | 5.00M |
| 486 | SGMT | Sagimet Biosciences Inc. | 435.97M | 2.92% | 397,356 | - |
| 487 | EBS | Emergent BioSolutions Inc. | 435.47M | 6.43% | 935,778 | 676.80M |
| 488 | EOLS | Evolus, Inc. | 434.64M | 9.45% | 1,184,003 | 301.79M |
| 489 | NGNE | Neurogene Inc. | 434.24M | 4.81% | 46,191 | 925.00K |
| 490 | VTVT | vTv Therapeutics Inc. | 430.86M | 5.40% | 35,576 | 36.84M |
| 491 | CLPT | ClearPoint Neuro, Inc. | 429.45M | 7.67% | 1,071,355 | 40.61M |
| 492 | KMDA | Kamada Ltd. | 425.62M | -0.14% | 51,297 | 181.68M |
| 493 | EPRX | Eupraxia Pharmaceuticals Inc. | 424.34M | 1.90% | 352,311 | - |
| 494 | OFIX | Orthofix Medical Inc. | 417.96M | 6.38% | 521,924 | 825.37M |
| 495 | CCRN | Cross Country Healthcare, Inc. | 409.00M | 0.53% | 1,312,037 | 1.00B |
| 496 | FBRX | Forte Biosciences, Inc. | 407.83M | -1.82% | 283,863 | - |
| 497 | PRLD | Prelude Therapeutics Incorporated | 404.64M | 11.48% | 399,893 | 16.72M |
| 498 | UPB | Upstream Bio, Inc. | 404.34M | -2.62% | 688,230 | 3.32M |
| 499 | CNXU | Conexeu Sciences Inc. | 404.32M | -5.04% | 76,831 | - |
| 500 | AIRS | AirSculpt Technologies, Inc. | 402.82M | 10.44% | 811,493 | 151.84M |